Can next-generation GLP-1 drugs help with healthy aging
Description Table of Contents Methodology GLP-1 Receptor Agonist Market size was valued at USD 44.5 Billion in 2023 and is projected to reach USD 95.4 Billion by 2031 , growing at a CAGR of 10.3% during the forecast period 2024-2031
This comes at a critical time: The GLP-1 injectable segment in India has exploded sales up ~177% YoY to 1,446 crore (MAT Feb 2026) driven by global blockbusters and rising obesity/diabetes burden (101M+ with diabetes, 136M+ pre-diabetes, hundreds of millions with obesity per WHO estimates)
Sabor frutas vermelhas intenso e refrescante Auxilia na resistncia durante exerccios longos Fcil de dosar e consumir Pode manchar superfcies se houver derramamento Concentrao de flavorizantes Nossas recomendaes de como escolher o produto foram teis para voc
KRAS is an oncogenic protein that is commonly activated in many tumors, including lung cancer and pancreatic cancer, and it has been considered an undruggable target because it lacks a classical drug binding site 143,144
